GKOS vs. SOLV: Glaukos vs. Solventum Stock Comparison
How do Glaukos (GKOS) and Solventum (SOLV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Glaukos (GKOS) and Solventum (SOLV) both belong to the Health Care Equipment & Supplies industry, though GKOS is classified under Health Care Equipment while SOLV falls under Health Care Supplies.
Glaukos (GKOS) has been public since June 25, 2015, giving it a longer listed trading history, while Solventum (SOLV) listed on March 26, 2024 and still has a shorter public-market record.
| Profile Item | GKOS | SOLV |
|---|---|---|
| Name | Glaukos Corp. | Solventum Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Supplies |
| Market Capitalization | 13.28 billion USD | 15.36 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | June 25, 2015 | March 26, 2024 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | GKOS | SOLV |
|---|---|---|
| Total Return (1Y) | 179.91% | 25.89% |
| Total Return (3Y, Annualized) | 55.51% | -- |
| Total Return (5Y, Annualized) | 35.14% | -- |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | GKOS | SOLV |
|---|---|---|
| Volatility (1Y, Annualized) | 61.24% | 30.06% |
| Beta (5Y) | 0.68 | 0.62 |
| Max Drawdown (5Y) | -53.68% | -39.98% |
| Avg. Volume (3M) | 1.15M | 1.05M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | GKOS | SOLV |
|---|---|---|
| Sharpe Ratio (1Y) | 2.87 | 0.72 |
| Sortino Ratio (1Y) | 5.93 | 1.08 |
Profitability
ROE (TTM)
Glaukos (GKOS) reports a negative ROE of -22.84%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Solventum (SOLV) reports 3.19%, ranking against industry peers normally.
GKOS
Health Care Equipment & Services industry group
-22.84%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- GKOS
- -22.84%
- Min
- -47.01%
SOLV
Health Care Equipment & Services industry group
3.19%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- SOLV
- 3.19%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Glaukos (GKOS) reports a negative net margin of -24.60%, usually indicating a net loss over the period. Meanwhile Solventum (SOLV) reports 1.91%, ranking against industry peers normally.
GKOS
Health Care Equipment & Services industry group
-24.60%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- GKOS
- -24.60%
- Min
- -28.46%
SOLV
Health Care Equipment & Services industry group
1.91%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- SOLV
- 1.91%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Glaukos (GKOS) at 0.39% and Solventum (SOLV) at 6.82% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.
GKOS
Health Care Equipment & Services industry group
0.39%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- GKOS
- 0.39%
- Q1
- -0.28%
- Min
- -16.29%
SOLV
Health Care Equipment & Services industry group
6.82%
- Max
- 35.43%
- Q3
- 14.14%
- SOLV
- 6.82%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | GKOS | SOLV |
|---|---|---|
| ROE (TTM) | -22.84% | 3.19% |
| ROA (TTM) | -3.90% | 2.29% |
| Net Margin (TTM) | -24.60% | 1.91% |
| Operating Margin (TTM) | 0.39% | 6.82% |
| Gross Margin (TTM) | 81.13% | 55.13% |
Growth
Revenue Growth
Glaukos (GKOS) at 32.33% sits in the top revenue growth quartile, while Solventum (SOLV) at 0.86% is in the bottom quartile, showing a clear gap in revenue momentum.
EPS Growth
Only one side can be read here: Solventum (SOLV) reports EPS growth of 221.74%, ranked against its industry; Glaukos (GKOS) has no EPS growth figure this period.
Growth Metrics
| Metric | GKOS | SOLV |
|---|---|---|
| Revenue Growth (YoY) | 32.33% | 0.86% |
| Revenue Growth (3Y CAGR) | 21.51% | 0.79% |
| EPS Growth (YoY) | -- | 221.74% |
| EPS Growth (3Y CAGR) | -- | 4.51% |
Financial Strength
Current Ratio (MRQ)
Glaukos (GKOS) at 4.57 carries current ratio above its industry’s typical mid-range, while Solventum (SOLV) at 1.03 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.
GKOS
Health Care Equipment & Services industry group
4.57
- Max
- 7.59
- GKOS
- 4.57
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
SOLV
Health Care Equipment & Services industry group
1.03
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- SOLV
- 1.03
- Min
- 0.30
Debt / Equity (MRQ)
Glaukos (GKOS) at 0.15 keeps leverage in the lower quartile, while Solventum (SOLV) at 1.10 sits in the higher-leverage quartile.
GKOS
Health Care Equipment & Services industry group
0.15
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- GKOS
- 0.15
- Min
- 0.00
SOLV
Health Care Equipment & Services industry group
1.10
- Max
- 1.88
- SOLV
- 1.10
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | GKOS | SOLV |
|---|---|---|
| Current Ratio (MRQ) | 4.57 | 1.03 |
| Debt / Equity (MRQ) | 0.15 | 1.10 |
| Net Debt / EBITDA | -- | 4.66 |
Dividends
Dividend Yield (TTM)
Neither Glaukos (GKOS) nor Solventum (SOLV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
GKOS
Health Care Equipment & Services industry group
0.00%
- GKOS
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Glaukos (GKOS) nor Solventum (SOLV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
GKOS
Health Care Equipment & Services industry group
0.00%
- GKOS
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | GKOS | SOLV |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: Solventum (SOLV) trades at 101.55 times trailing earnings, ranked against its peers, while Glaukos (GKOS) has no P/E ratio this period.
GKOS
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- GKOS
- --
SOLV
Health Care Equipment & Services industry group
101.55
- SOLV
- 101.55
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Solventum (SOLV) at 1.88 prices around its industry’s typical P/S ratio, while Glaukos (GKOS) at 19.24 clears its benchmark range — GKOS looks notably rich on sales.
GKOS
Health Care Equipment & Services industry group
19.24
- GKOS
- 19.24
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
SOLV
Health Care Equipment & Services industry group
1.88
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- SOLV
- 1.88
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Solventum (SOLV) at 3.20 sits near its industry’s typical P/B ratio, while Glaukos (GKOS) at 18.51 prices above its benchmark range — GKOS looks rich relative to book.
GKOS
Health Care Equipment & Services industry group
18.51
- GKOS
- 18.51
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
SOLV
Health Care Equipment & Services industry group
3.20
- Max
- 11.68
- Q3
- 6.12
- SOLV
- 3.20
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | GKOS | SOLV |
|---|---|---|
| P/E Ratio (TTM) | -- | 101.55 |
| P/S Ratio (TTM) | 19.24 | 1.88 |
| P/B Ratio (MRQ) | 18.51 | 3.20 |
| Free Cash Flow Yield (TTM) | 0.40% | 1.31% |